Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Stepanova

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PROZobair M Younossi, Arian Afendy, Maria Stepanova, et al.
Journal of Hepatology|August 26, 2018
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair Younossi, Maria Stepanova, Arun J Sanyal, et al.
Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
International Journal of General Medicine|May 1, 2023
Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute InfectionJillian Kallman Price, Lynn H Gerber, Maria Stepanova, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2021
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World ExperienceJohn Paul Verderese, Maria Stepanova, Brian Lam, et al.
American Journal of Physical Medicine & Rehabilitation|February 8, 2023
Regular Exercise Is Associated With Low Fatigue Levels and Good Functional Outcomes After COVID-19: A Prospective Observational StudyLeyla de Avila, Jillian K Price, Maria Stepanova, et al.
Acta Neuropathologica|April 17, 2026
A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann-Sträussler-Scheinker disease mutationAndrew Fang, Xinli Tang, Madeleine Fleming, et al.
Journal of Hepatology|June 25, 2017
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled studyChristophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2019
Reduced Patient-Reported Outcome Scores Associate With Level of Fibrosis in Patients With Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Quentin M Anstee, et al.
Hepatology (Baltimore, Md.)|November 21, 2017
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PROZobair M Younossi, Arian Afendy, Maria Stepanova, et al.
Journal of Hepatology|August 26, 2018
The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair Younossi, Maria Stepanova, Arun J Sanyal, et al.
Hepatology Communications|July 19, 2021
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic SteatohepatitisZobair M Younossi, Maria Stepanova, Mazen Noureddin, et al.
International Journal of General Medicine|May 1, 2023
Post-Acute SARS-CoV-2 Symptoms are Fewer, Less Intense Over Time in People Treated with Mono-Clonal Antibodies for Acute InfectionJillian Kallman Price, Lynn H Gerber, Maria Stepanova, et al.
Hepatology Communications|July 26, 2022
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver RegistryZobair M Younossi, Yusuf Yilmaz, Mohamed El-Kassas, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 24, 2021
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World ExperienceJohn Paul Verderese, Maria Stepanova, Brian Lam, et al.
American Journal of Physical Medicine & Rehabilitation|February 8, 2023
Regular Exercise Is Associated With Low Fatigue Levels and Good Functional Outcomes After COVID-19: A Prospective Observational StudyLeyla de Avila, Jillian K Price, Maria Stepanova, et al.
Acta Neuropathologica|April 17, 2026
A model-based prion vaccine protects a transgenic mouse line carrying a Gerstmann-Sträussler-Scheinker disease mutationAndrew Fang, Xinli Tang, Madeleine Fleming, et al.
Journal of Hepatology|June 25, 2017
Alfapump® system vs. large volume paracentesis for refractory ascites: A multicenter randomized controlled studyChristophe Bureau, Danielle Adebayo, Mael Chalret de Rieu, et al.
Pageof 25